Year archive

NEUREN PHARMACEUTICALS LIMITED — 2012 filings

All 33 regulatory filings released by NEUREN PHARMACEUTICALS LIMITED (NEU) in 2012, sourced directly from the official regulator.

33 Filings

2012 Period

2012 filings (33)

Filing	Released	Lang
Neuren IND open for Rett Phase II trial 2 pages 246.0KB Regulatory Filings	2012-12-23	English
Appendix 3B 8 pages 281.5KB Capital/Financing Update	2012-12-19	English
Neuren TAP Conference presentation and Fragile X results 16 pages 894.8KB Investor Presentation	2012-11-29	English
Neuren completes Phase I NNZ2566 study/files Phase II IND 2 pages 185.5KB Regulatory Filings	2012-11-21	English
Change in substantial holding 5 pages 77.6KB Regulatory Filings	2012-11-08	English
Amended Change in substantial holding 5 pages 77.9KB Regulatory Filings	2012-11-08	English
Amended 2 - Change in substantial holding 5 pages 77.7KB Regulatory Filings	2012-11-08	English
Appendix 4C - quarterly 6 pages 225.3KB Interim / Quarterly Report	2012-10-30	English
Response to ASX Price Query 3 pages 151.8KB Regulatory Filings	2012-10-24	English
NNZ2566 selected as Windhover Top 10 Neuroscience Project 2 pages 247.5KB Regulatory Filings	2012-10-18	English
Half Yearly Report and Accounts 18 pages 639.2KB Interim / Quarterly Report	2012-08-29	English
Neuren appoints Joe Horrigan VP Clinical and Medical Affairs 2 pages 181.1KB Board/Management Information	2012-08-08	English
NNZ2566 Rationale in ASDs 17 pages 1.4MB Investor Presentation	2012-08-06	English
Appendix 4C - quarterly 6 pages 214.6KB Interim / Quarterly Report	2012-07-30	English
Neuren awarded Rett Syndrome trial grant 2 pages 223.8KB Regulatory Filings	2012-07-05	English
Final Director`s Interest Notice 2 pages 15.5KB Director's Dealing	2012-06-07	English
Initial Director`s Interest Notice 2 pages 14.7KB Director's Dealing	2012-06-07	English
CEO`s address to AGM 12 pages 116.3KB Investor Presentation	2012-05-30	English
Results of Meeting 1 page 63.1KB Declaration of Voting Results & Voting Rights Announcements	2012-05-30	English
Neuren announces cancer xenograft testing results 2 pages 147.5KB Regulatory Filings	2012-05-28	English
Change in substantial holding 5 pages 104.6KB Regulatory Filings	2012-05-24	English
Rett Syndrome pre-IND meeting held with FDA 2 pages 50.0KB Regulatory Filings	2012-05-15	English
Notice under section 708A(5)(e) of the Corporations Act 1 Share Issue/Capital Change	2012-05-01	English
Appendix 4C - quarterly 6 pages 117.4KB Interim / Quarterly Report	2012-04-29	English
Notice of Annual General Meeting/Proxy Form 12 pages 183.2KB AGM Information	2012-04-26	English
Appendix 3B (exercise of options) 8 pages 73.4KB Capital/Financing Update	2012-04-26	English
Response to ASX Price Query 3 pages 123.2KB Regulatory Filings	2012-04-18	English
Neuren 2011 Annual Report 40 pages 1.3MB Annual Report	2012-03-29	English
Neuren presentation to Arrowhead TBI Conference 28 pages 842.4KB Investor Presentation	2012-03-07	English
Neuren appoints Bruce Hancox to board of directors 1 Board/Management Information	2012-03-07	English
Initial Director`s Interest Notice 2 pages 13.1KB Director's Dealing	2012-03-07	English
Neuren 2011 Preliminary Final Report 10 pages 69.8KB Annual Report	2012-02-28	English
Appendix 4C - quarterly 6 pages 148.4KB Interim / Quarterly Report	2012-01-30	English

Filings by year

2026 42 filings
2025 130 filings
2024 68 filings
2023 46 filings
2022 36 filings
2021 60 filings
2020 56 filings
2019 33 filings
2018 40 filings
2017 47 filings
2016 31 filings
2015 39 filings
2014 50 filings
2013 77 filings
2012 33 filings
2011 86 filings
2010 71 filings
2009 55 filings
2008 57 filings
2007 53 filings
2006 51 filings
2005 57 filings